China approves Sinopharm and Sinovac jabs for emergency use for children aged 3 to 17
CGTN, 12 Jun 2021
For more:
https://news.cgtn.com/news/2021-06-12/China-approves-vaccines-for-emergency-use-for-children-aged-3-17-1123CSElSuc/index.html
The #Sinopharm and #Sinovac #vaccines have been approved by Chinese health authorities for conditional marketing. Following their authorization for adults, they have continued to carry out expanded clinical trials, and they have been proven safe for the 3 to 17 age group after careful evaluation and expert reviews. The results show that these vaccines have a strong capability to induce the production of antibodies.
Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
https://news.cgtn.com/news/2021-06-12/China-approves-vaccines-for-emergency-use-for-children-aged-3-17-1123CSElSuc/index.html
The #Sinopharm and #Sinovac #vaccines have been approved by Chinese health authorities for conditional marketing. Following their authorization for adults, they have continued to carry out expanded clinical trials, and they have been proven safe for the 3 to 17 age group after careful evaluation and expert reviews. The results show that these vaccines have a strong capability to induce the production of antibodies.
Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
